{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:00:55Z","timestamp":1788843655941,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"am","delay-in-days":266,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NS097490"],"award-info":[{"award-number":["NS097490"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bbapap.2024.141027","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T18:52:47Z","timestamp":1716490367000},"page":"141027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of the interfacial regions in misfolded transthyretin oligomers"],"prefix":"10.1016","volume":"1872","author":[{"given":"Anvesh K.R.","family":"Dasari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew F.","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah B.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Hun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2024.141027_bb0005","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1039\/C9CS00199A","article-title":"Half a century of amyloids: past, present and future","volume":"49","author":"Ke","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bbapap.2024.141027_bb0010","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature02261","article-title":"Protein folding and misfolding","volume":"426","author":"Dobson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bbapap.2024.141027_bb0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"Chiti","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbapap.2024.141027_bb0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.abb.2007.05.015","article-title":"Folding versus aggregation: polypeptide conformations on competing pathways","volume":"469","author":"Jahn","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2024.141027_bb0025","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s00018-009-0109-0","article-title":"Transthyretin: the servant of many masters","volume":"66","author":"Buxbaum","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbapap.2024.141027_bb0030","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1212\/WNL.36.7.900","article-title":"Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award","volume":"36","author":"Herbert","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.bbapap.2024.141027_bb0035","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","article-title":"Fibril in senile systemic amyloidosis is derived from normal transthyretin","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbapap.2024.141027_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/03007995.2012.754348","article-title":"THAOS - the transthyretin amyloidosis outcomes survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis","volume":"29","author":"Coelho","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"issue":"Suppl. 1","key":"10.1016\/j.bbapap.2024.141027_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/13506129.2003.12088568","article-title":"Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations","volume":"10","author":"Westermark","year":"2003","journal-title":"Amyloid"},{"key":"10.1016\/j.bbapap.2024.141027_bb0050","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1212\/WNL.47.4.988","article-title":"Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene","volume":"47","author":"Herrick","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.bbapap.2024.141027_bb0055","first-page":"54","article-title":"Tabulation of transthyretin (TTR) variants as of 1\/1\/2000","volume":"7","author":"Connors","year":"2000","journal-title":"Amyloid-Int. J. Exp. Clin. Investig."},{"key":"10.1016\/j.bbapap.2024.141027_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/humu.1380050302","article-title":"Transthyretin mutations in health and disease","volume":"5","author":"Saraiva","year":"1995","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbapap.2024.141027_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2019.07.022","article-title":"Cardiac amyloidosis: an underdiagnosed\/underappreciated disease","volume":"67","author":"Manolis","year":"2019","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.bbapap.2024.141027_bb0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-med-052918-020140","article-title":"Cardiac amyloidosis: overlooked, underappreciated, and treatable","volume":"71","author":"Rubin","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbapap.2024.141027_bb0075","first-page":"703","article-title":"Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis","volume":"73","author":"Gustavsson","year":"1995","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bbapap.2024.141027_bb0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/13506129.2013.797890","article-title":"Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis","volume":"20","author":"Ihse","year":"2013","journal-title":"Amyloid"},{"key":"10.1016\/j.bbapap.2024.141027_bb0085","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/bi952501g","article-title":"The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid","volume":"35","author":"Lai","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2024.141027_bb0090","doi-asserted-by":"crossref","first-page":"17851","DOI":"10.1021\/bi981876+","article-title":"Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation","volume":"37","author":"Lashuel","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2024.141027_bb0095","doi-asserted-by":"crossref","first-page":"27207","DOI":"10.1074\/jbc.M101024200","article-title":"Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants","volume":"276","author":"Quintas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2024.141027_bb0100","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15252\/emmm.201505357","article-title":"A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis","volume":"7","author":"Marcoux","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbapap.2024.141027_bb0105","doi-asserted-by":"crossref","first-page":"E6428","DOI":"10.1073\/pnas.1802977115","article-title":"Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease","volume":"115","author":"Klimtchuk","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbapap.2024.141027_bb0110","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/acs.biochem.0c00079","article-title":"Disruption of the CD loop by enzymatic cleavage promotes the formation of toxic transthyretin oligomers through a common transthyretin misfolding pathway","volume":"59","author":"Dasari","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2024.141027_bb0115","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1073\/pnas.1317488111","article-title":"Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis","volume":"111","author":"Mangione","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbapap.2024.141027_bb0120","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.RA118.003990","article-title":"Plasminogen activation triggers transthyretin amyloidogenesis in vitro","volume":"293","author":"Mangione","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2024.141027_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7621","article-title":"Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients","volume":"9","author":"Schonhoft","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbapap.2024.141027_bb0130","doi-asserted-by":"crossref","first-page":"29639","DOI":"10.1074\/jbc.R800016200","article-title":"Structural classification of toxic amyloid oligomers","volume":"283","author":"Glabe","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2024.141027_bb0135","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1213151","article-title":"Atomic view of a toxic amyloid small oligomer","volume":"335","author":"Laganowsky","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2024.141027_bb0140","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pneurobio.2012.03.002","article-title":"Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits","volume":"99","author":"Stefani","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbapap.2024.141027_bb0145","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jmb.2012.01.006","article-title":"Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity","volume":"421","author":"Fandrich","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbapap.2024.141027_bb0150","first-page":"1994","article-title":"Structural characterization of toxic oligomers that are kinetically trapped during alpha-synuclein fibril formation","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbapap.2024.141027_bb0155","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1073\/pnas.0400062101","article-title":"Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture","volume":"101","author":"Reixach","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbapap.2024.141027_bb0160","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.aan6160","article-title":"Structural basis of membrane disruption and cellular toxicity by alpha-synuclein oligomers","volume":"358","author":"Fusco","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bbapap.2024.141027_bb0165","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1039\/C9CS00199A","article-title":"Half a century of amyloids: past, present and future","volume":"49","author":"Ke","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bbapap.2024.141027_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21937-3","article-title":"The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells","volume":"12","author":"Cascella","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbapap.2024.141027_bb0175","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1471-4159.2006.04210.x","article-title":"Transthyretin oligomers induce calcium influx via voltage-gated calcium channels","volume":"100","author":"Hou","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbapap.2024.141027_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-37230-1","article-title":"Transthyretin aggregation pathway toward the formation of distinct cytotoxic oligomers","volume":"9","author":"Dasari","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbapap.2024.141027_bb0185","doi-asserted-by":"crossref","first-page":"28932","DOI":"10.1074\/jbc.M115.659912","article-title":"Uncovering the mechanism of aggregation of human transthyretin","volume":"290","author":"Saelices","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2024.141027_bb0190","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1021\/bi00151a036","article-title":"Partial denaturation of transthyretin is sufficient for amyloid fibril formation Invitro","volume":"31","author":"Colon","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2024.141027_bb0195","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1021\/bi952501g","article-title":"The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid","volume":"35","author":"Lai","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2024.141027_bb0200","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.1021\/acs.biochem.6b00649","article-title":"Solid-state NMR studies reveal native-like beta-sheet structures in transthyretin amyloid","volume":"55","author":"Lim","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2024.141027_bb0205","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1021\/acs.biochem.7b00658","article-title":"Pathogenic mutations induce partial structural changes in the native beta-sheet structure of transthyretin and accelerate aggregation","volume":"56","author":"Lim","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2024.141027_bb0210","doi-asserted-by":"crossref","first-page":"11442","DOI":"10.1021\/bi011194d","article-title":"An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured","volume":"40","author":"Jiang","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2024.141027_bb0215","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41467-019-08609-z","article-title":"A molecular mechanism for transthyretin amyloidogenesis","volume":"10","author":"Yee","year":"2019","journal-title":"Nat. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963924000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963924000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T11:13:12Z","timestamp":1722078792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963924000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1570963924000347"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2024.141027","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of the interfacial regions in misfolded transthyretin oligomers","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2024.141027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"141027"}}